Bio-Rad Laboratories, Inc. a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the availability of Biogazelle’s qbasePLUS, qPCR data ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), today announced the global launch of its CFX Opus 96 and CFX Opus 384 Real-time PCR Systems along with BR.io, a cloud-based instrument connectivity, ...
DUBLIN--(BUSINESS WIRE)--The "Real-time PCR (qPCR) andDigital PCR (dPCR) Market Analysis by Technology, by Product (Consumables & Reagents, Instruments, Software & Services), by Application and ...
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Duet Real-Time PCR System to support researchers in ...
HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO and BIO.B), a life sciences company with a market capitalization of $6.8 billion and strong financial health according to InvestingPro data, ...
The CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems represent the next generation of the company’s CFX Real-Time PCR Systems that are used in research and genomic testing as well as in pathogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results